PACB vs PG · rev $38.4M vs P/E 25, rev $84.28B
Pacific Biosciences of California (PACB) versus Procter & Gamble Company (PG) — a side-by-side from cached financials, not a winner call.
Pacific Biosciences of California (PACB) is a medical devices company listed on US.
Procter & Gamble Company (PG) is a household & personal products company listed on US. It is led by Jon Moeller.
Latest reported PACB revenue for 2025-09-30 was $38.4M. Net income was -$38.0M. Revenue was down 3.3% from 2025-06-30 to 2025-09-30. PACB currently screens at market cap $387.1M.
Latest reported PG revenue for 2025-06-30 was $84.28B. Net income was $15.97B. PG currently screens at market cap $373.53B and trailing P/E 25.3.
PACB currently screens at market cap $387.1M. PG currently screens at market cap $373.53B and trailing P/E 25.3.
Not investment advice. Open the PACB and PG stock pages for the full models.
Not investment advice.